ICS Begins European Study for Next-Generation Emblok EPS

March 2, 2021—Innovative Cardiovascular Solutions (ICS) announced the success of the first European clinical cases using the company’s next-generation Emblok embolic protection system (EPS) in patients undergoing transcatheter aortic valve replacement (TAVR). The procedures were performed by Federico De Marco, MD, at IRCCS Policlinico San Donato in Milan, Italy.

According to ICS, the Emblok EPS is designed to provide complete circumferential aortic coverage to capture and remove embolic debris released during TAVR procedures, preventing debris from reaching cerebral and peripheral vascular circulation.

“The Emblok system performed exceptionally well,” commented Dr. De Marco in the company’s announcement. “We experienced smooth insertion and precise filter positioning in patients with challenging anatomy.”

Dr. De Marco continued, “We were able to successfully pass interventional devices, including the TAVR system, beyond the filter without any device interaction, enabling complete embolic protection during the duration of the TAVR procedure. We are extremely enthusiastic with the initial results of the Emblok system.”